| scholarly article | Q13442814 |
| P50 | author | John F Engelhardt | Q56999987 |
| P2093 | author name string | Y Zhang | |
| J Yang | |||
| P Sharma | |||
| Z Yan | |||
| D Duan | |||
| Y Ye | |||
| L Dudus | |||
| Y Yue | |||
| R Lester | |||
| K J Fisher | |||
| S Sanlioglu | |||
| P2860 | cites work | Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors | Q43716886 |
| Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction | Q45758768 | ||
| Structural alterations and conformational dynamics in Holliday junctions induced by binding of a site-specific recombinase | Q47858509 | ||
| Resolution of recombination intermediates by a mammalian activity functionally analogous to Escherichia coli RuvC resolvase. | Q54639997 | ||
| Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein | Q64380916 | ||
| Retroviral DNA integration | Q70092316 | ||
| The kinetics of rAAV integration in the liver | Q74557678 | ||
| Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue | Q24523651 | ||
| Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors | Q24682739 | ||
| Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis | Q24684374 | ||
| Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector | Q34188887 | ||
| Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats. | Q35881175 | ||
| Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus | Q36159178 | ||
| Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression | Q36599393 | ||
| The palindromic LTR-LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration. | Q36828275 | ||
| Adeno-associated virus general transduction vectors: analysis of proviral structures | Q36868692 | ||
| A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication | Q36919184 | ||
| The recombination signals for adeno-associated virus site-specific integration | Q37453579 | ||
| Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers | Q39873805 | ||
| In vivo model of adeno-associated virus vector persistence and rescue | Q39874425 | ||
| Adenovirus replication and transcription sites are spatially separated in the nucleus of infected cells | Q40793651 | ||
| Adeno-associated virus: integration at a specific chromosomal locus | Q40852243 | ||
| Structural and functional heterogeneity of integrated recombinant AAV genomes | Q41118391 | ||
| Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells | Q41128137 | ||
| Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration | Q41431346 | ||
| Processing of recombination intermediates by the RuvABC proteins | Q41689455 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. | Q42524846 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 161-169 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene expression | |
| P478 | volume | 73 |
| Q33659389 | AAV's anatomy: roadmap for optimizing vectors for translational success |
| Q52743732 | Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes. |
| Q41845943 | Adeno-associated virus replication induces a DNA damage response coordinated by DNA-dependent protein kinase |
| Q39798744 | Adeno-associated virus site-specific integration is mediated by proteins of the nonhomologous end-joining pathway |
| Q39778963 | Adeno-associated virus small rep proteins are modified with at least two types of polyubiquitination |
| Q36845715 | Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle |
| Q37066323 | Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo. |
| Q33576852 | Characterization of genome integrity for oversized recombinant AAV vector |
| Q34857785 | Consequences of DNA-dependent protein kinase catalytic subunit deficiency on recombinant adeno-associated virus genome circularization and heterodimerization in muscle tissue |
| Q41093443 | Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors |
| Q39694559 | Differential effects of DNA double-strand break repair pathways on single-strand and self-complementary adeno-associated virus vector genomes |
| Q42755152 | Effects of adeno-associated virus DNA hairpin structure on recombination |
| Q33604753 | Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation |
| Q34433170 | Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. |
| Q34997245 | Enhancement of Recombinant Adeno-Associated Virus Type 2-Mediated Transgene Expression in a Lung Epithelial Cell Line by Inhibition of the Epidermal Growth Factor Receptor |
| Q33730469 | Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb. |
| Q39257264 | HPV-16 E1, E2 and E6 each complement the Ad5 helper gene set, increasing rAAV2 and wt AAV2 production |
| Q35139314 | Host cell DNA repair pathways in adeno-associated viral genome processing |
| Q34447817 | Hot topics in adeno-associated virus as a gene transfer vector |
| Q37682933 | Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction |
| Q40726705 | Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes |
| Q36489339 | Investigation of the peak action wavelength of light-activated gene transduction |
| Q24792050 | Long term physiologic modification using rAAV in utero gene-therapy |
| Q33824969 | Overexpression of cyclin A inhibits augmentation of recombinant adeno-associated virus transduction by the adenovirus E4orf6 protein |
| Q57092477 | Pathogenesis and management of adenoviral keratoconjunctivitis |
| Q37731874 | Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle |
| Q36953325 | Recombinant adeno-associated virus transduction and integration |
| Q33811409 | Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo |
| Q40075782 | The Mre11/Rad50/Nbs1 complex limits adeno-associated virus transduction and replication |
| Q36099356 | The role of DNA-PKcs and artemis in opening viral DNA hairpin termini in various tissues in mice |
| Q35799349 | Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy |
Search more.